论文部分内容阅读
一、转移性肝癌治疗现状转移性肝癌(metastaticlivercancer:MLC)多较原发性肝癌(Primarylivercancer:PLC)的肿瘤血管少,故不易期望取得TAE等经动脉疗法的效果,而又因其纤维成分多故亦难于采用经皮乙醇注射疗法(PEIT)治疗。以动脉注射贮存器注射抗癌药的肝动脉注射疗法可谓内科
First, the treatment of metastatic liver cancer status metastatic liver cancer (metastaticlivercancer: MLC) more than primary liver cancer (Primarylivercancer: PLC) less tumor blood vessels, it is not easy to expect TAE and other arterial therapies, but because of its fiber content and more It is also difficult to use percutaneous ethanol injection therapy (PEIT) treatment. Injection of anti-cancer drugs to the arterial injection reservoir injection of hepatic artery can be described as internal medicine